Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives
Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, et al
& Pratt, W
Its well-rounded benefits, affordability, and favorable reviews suggest it offers considerable potential in meeting diverse wellness goals
Redox Biol 2023;63:102749.ArticlePubMedPMC 50
GLP-1 medications work by High levels of the GLP-1 hormone can also reduce your appetite and increase feelings of fullness by slowing the rate at which your stomach empties, which can aid with weight management